Revolution Medicines, Inc. is 4.7x more valuable than Vaxcyte, Inc. by market capitalization ($30.65 B vs $6.56 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PCVX | RVMD |
|---|---|---|
| Market cap | $6.56 B | $30.65 B |
| US-listed rank | #1195 | #454 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$766.63K | -$1.13B |
| SEC filings | 690 | 782 |
Revolution Medicines, Inc. is 4.7x more valuable than Vaxcyte, Inc. by market capitalization ($30.65 B vs $6.56 B).
Full pages: Vaxcyte, Inc. and Revolution Medicines, Inc., or browse the full rankings.